Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • REICH K
    • LI Q
    • LIU K
    • LA ROSA C
    • GREEN S
    • KIMBALL AB
    • PAPP KA
    • BLAUVELT A
    • TYRING SK
    • PROF Rodney Sinclair
    • THACI D
    • NOGRALES K
    • MEHTA A
    • CICHANOWITZ N

Published in

  • The Lancet

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(17)31279-5

Additional Document Info

Parent Title

  • LANCET

Volume

  • 390

Issue

  • 10091

Publisher

  • Lancet